Page last updated: 2024-10-17

aminocaproic acid and Sepsis

aminocaproic acid has been researched along with Sepsis in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.

Research Excerpts

ExcerptRelevanceReference
"The rate of neonatal intracranial hemorrhage was not significantly different between the 2 groups (P =."1.32Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review. ( Arnold, JH; Betit, P; Chang, RW; Downard, CD; Garza, JJ; Wilson, JM, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Downard, CD1
Betit, P1
Chang, RW1
Garza, JJ1
Arnold, JH1
Wilson, JM1

Other Studies

1 other study available for aminocaproic acid and Sepsis

ArticleYear
Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review.
    Journal of pediatric surgery, 2003, Volume: 38, Issue:8

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Child; Child, Preschool; Extracorporeal Membrane

2003